Thursday April 24, 7:00 am ET
Company CEO to Provide Update and Insights Into Business Strategy Implementation
BURBANK, CA--(MARKET WIRE)--Apr 24, 2008 -- Imaging3(TM), Inc. (OTC BB: IMGG.OB), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, announced today that on Tuesday, April 29, 2008 at 3:00pm PDT, the company's CEO, Mr. Dean Janes, will be hosting a conference call to provide an update on the state of the company. Mr. Janes will be discussing the company's progress in bringing the Dominion(TM) product to market.
To join the conference call, please call 1-866-212-0875 and enter passcode 172951 followed by the # pound sign. You will be connected to the conference call in a listen only mode, and then lines will be opened for questions following the presentation.
About Imaging3
Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company's website at http://www.imaging3.com for more information.
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive, and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.
For Further Information, Contact:
RedChip Companies, Inc.
500 Winderley Place, Suite 100, Orlando, FL 32751,
(800) 733-2447,Fax: (407) 644-0758,
info@redchip.com
Friday, April 25, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment